Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 374

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

Open access
Butler, A., Hill, J.M., Ireland, S.J., Jordan, C.C., Tyers, M.B.·1988·British Journal of Pharmacology

Abstract

This paper describes the pharmacology of the novel 5‐hydroxytryptamine 3 (5‐HT3) receptor antagonist GR38032F. On the isolated vagus nerve and superior cervical ganglion of the rat, R,S‐GR38032F behaved as a reversible competitive antagonist of 5‐HT‐induced depolarization with pK B values of 8.61 ± 0.08 (n = 19) and 8.13 ± 0.07 (n = 16), respectively. The resolved R‐ and S‐isomers of GR38032F were approximately equipotent as 5‐HT antagonists on the rat vagus nerve: the pK B values were 8.95 ± 0.05 (n = 16) and 8.63 ± 0.08 (n = 17), respectively. R,S‐GR38032F was also an effective antagonist of 5‐HT on the rabbit isolated vagus nerve: in this case the pK B value was 9.40 ±0.14 (n = 4). On the rabbit isolated heart, low concentrations of R,S‐GR38032F (3 × −10 11 −1 × 10‐9 m) antagonized the positive chronotropic effect of 5‐HT and 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT). However, the effects of the compound did not appear consistent with simple reversible competition. On the longitudinal smooth muscle of the guinea‐pig ileum, R,S‐GR38032F caused concentration‐dependent parallel rightward displacement of the 2‐methyl‐5‐HT concentration‐contraction response curve; in contrast, a portion of the response to 5‐HT appeared resistant to R,S‐GR38032F. pK B values estimated from the effects of the compound against 2‐methyl‐5‐HT or the inhibitable portion of the response to 5‐HT were 7.31 ± 0.06 (n = 8) and 7.33 ± 0.13 (n = 8), respectively. Against 2‐methyl‐5‐HT, R‐GR38032F seemed more potent (pK B 7.20 ± 0.10; n = 6) than S‐GR38032F (pK B 6.30 ± 0.05; n = 6). R,S‐GR38032F is highly selective for 5‐HT3 receptors, and at concentrations of 3 × 10−6‐3 × 10−5m, had negligible agonist or antagonist activity on other 5‐HT or non‐5‐HT receptor‐containing tissues on which it was tested. The potency and duration of action of R,S‐GR38032F in blocking 5‐HT 3 receptors in vivo were assessed by measuring its ability to antagonize the bradycardic response to 5‐HT or 2‐methyl‐5‐HT administered intravenously (i.v.) to anaesthetized animals. For i.v. administration to the rat, the ED 50 for R,S‐GR38032F against 2‐methyl‐5‐HT (100 μg kg−1) was 0.4 (95% confidence limits 0.18–0.87) μg kg−1 (n = 10); the corresponding value for oral administration to this species was 7.0 (3.0–22.0) μg kg−1 (n = 8–10 per dose level). R,S‐GR38032F was similarly effective in the anaesthetized cat. The present results are discussed with reference to the postulated existence of subtypes of the 5‐HT3 receptor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1988.tb11542.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 374

Metadata

Authors
Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., & Tyers, M. B.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1988-06
Volume
94
Issue
2
Pages
397-412
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2010163969
Cited by
374
References
17
FWCI
12.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.1988.tb11542.x
The paper
Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., & Tyers, M. B. (1988). Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1988.tb11542.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.